Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis
about
Aberrant overexpression of the cell polarity module scribble in human cancerMolecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesotheliomaApoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesotheliomamiR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways.An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.A new target for proteasome inhibitors: FoxM1Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma.Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.
P2860
Q28236961-ECF1E666-3D4F-494C-B1E7-24D20269F5C1Q28482133-8FE847F6-458F-46F2-8339-560F4B48011CQ33999822-A9BABEB8-5901-45E5-8B71-26F664992974Q35656084-91291F0B-8B42-48E4-A3E6-EEBF49608850Q35842155-71BBF5B6-FCA0-457F-9BCF-0069C4625504Q36882572-619714D0-950E-4F5F-AF33-12ADF9D79746Q37141355-5CA73724-E2F0-4C24-A3DD-90E35E52C2F7Q37507415-AB18BAE3-8F2E-4D9A-9683-00D368C24ED6Q37674617-A1823C1D-C047-4829-84A6-87AF5C835BD0Q37692445-B0C9A247-6AB3-4BF3-9D9F-826D810D31ACQ38699407-6037B17B-D4C2-43DA-839A-E06CAFD22F1AQ38815782-D28DAD94-FC40-46C9-8769-301FC451D628Q39042562-13D6300D-723A-43A8-AB5D-6B4F6BE45DBDQ39991261-3F398C64-C477-47E1-9268-D9887EFBF0D9Q43444340-031D4F4B-7B25-46DA-9316-2F2097F434F9Q49996923-2EDADE1D-BBD2-4BB6-A465-70CC3900BBC1Q52672878-1D4383CD-9567-4B3A-98E4-31DF9602EF6D
P2860
Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of potential th ...... cycle gene expression analysis
@en
Identification of potential th ...... ycle gene expression analysis.
@nl
type
label
Identification of potential th ...... cycle gene expression analysis
@en
Identification of potential th ...... ycle gene expression analysis.
@nl
prefLabel
Identification of potential th ...... cycle gene expression analysis
@en
Identification of potential th ...... ycle gene expression analysis.
@nl
P2093
P2860
P1476
Identification of potential th ...... cycle gene expression analysis
@en
P2093
Anna Catania
Antonio Marchetti
Caterina Pellegrini
Ester Fasoli
Guido Coggi
Luigi Santambrogio
Massimo Roncalli
Monica Falleni
Silvano Bosari
Solange Romagnoli
P2860
P304
P356
10.2353/AJPATH.2009.080721
P407
P577
2009-02-13T00:00:00Z